Cleveland Clinic Fairview Hospital
Cleveland, Ohio 44195
7 studies enrolling now · 23 studies all time
What they study most
Anxiety Disorders, Bleeding, Blood Pressure, CIN 2/3, COVID-19, Carcinoma, Ovarian Epithelial, Catecholamine-resistant Hypotension (CRH), Cervical Cancer, Cervical Dysplasia, Colorectal Disorders, Coronavirus Infection, Depressive Disorder, Major
Studies at this site
- Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer — Recruiting now
- Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery — Recruiting now
- Sugammadex Vs Neostigmine in Reversing Neuromuscular Blocks in Outpatient ERCP. A Randomized, Double-Blinded Trial — Recruiting now
- Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3) — Recruiting now
- The GUARDIAN Trial — Recruiting now
- Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3) — Recruiting now
- Intravenous Oliceridine and Opioid-related Complications — Completed
- Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery — Running, not enrolling
- Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer — Completed
- Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia — Running, not enrolling
- The GUARDIAN Trial - Vasopressor Sub-Study — Enrolling by invitation
- The GUARDIAN Trial - Induction Agent Sub-Study — Enrolling by invitation
- My Recordable On-Demand Audio Discharge Instructions — Completed
- Danger Signs in Heart Failure- Effects of Video Education — Completed
- Novel Experimental COVID-19 Therapies Affecting Host Response — Completed
- Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3) — Completed
- Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer — Stopped early
- Assessing the Effects of Sublingual Sufentanil 30 µg on Postoperative Recovery — Stopped early
- Virtual Reality Distraction for Reduction — Completed
- A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208) — Completed
- Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management — Stopped early
- Promote Access to Stop Suicide: Comparison of Follow up Services for Youth at Risk for Suicide — Completed
- A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension — Completed